Crescent Biopharma Ord Shs
CBIO13.500USD
+1.720+14.60%
Close 03/26, 16:00（ET）Quotes delayed by 15 min
8.71MMarket Cap
LossP/E TTM
More Details of Company
Crescent Biopharma Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Crescent Biopharma Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Bruce Johnson
Mr. Bruce Johnson
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
--
--
Mr. Chinmaya Rath
Mr. Chinmaya Rath
Senior Vice President, Chief Business Officer
Senior Vice President, Chief Business Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Bruce Johnson
Mr. Bruce Johnson
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
--
--
Mr. Chinmaya Rath
Mr. Chinmaya Rath
Senior Vice President, Chief Business Officer
Senior Vice President, Chief Business Officer
--
--
Revenue Breakdown
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
10.00K
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Feb 19
Updated: Thu, Feb 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
15.00%
BVF Partners L.P.
9.97%
Fairmount Funds Management LLC
9.97%
VR Adviser, LLC
7.74%
Forbion Capital Partners
6.09%
Other
51.22%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
15.00%
BVF Partners L.P.
9.97%
Fairmount Funds Management LLC
9.97%
VR Adviser, LLC
7.74%
Forbion Capital Partners
6.09%
Other
51.22%
Shareholder Types
Shareholders
Proportion
Hedge Fund
36.98%
Investment Advisor
21.27%
Venture Capital
16.01%
Investment Advisor/Hedge Fund
10.96%
Corporation
5.17%
Private Equity
1.65%
Individual Investor
0.99%
Research Firm
0.63%
Pension Fund
0.04%
Other
6.31%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
74
14.38M
82.13%
--
2025Q4
127
14.27M
51.79%
+2.00M
2025Q3
130
11.32M
81.48%
+344.37K
2025Q2
131
10.75M
77.39%
+10.23M
2025Q1
123
307.17K
47.59%
-204.60K
2024Q4
132
303.23K
47.01%
-167.56K
2024Q3
125
177.68K
27.55%
-170.88K
2024Q2
126
261.75K
40.60%
-129.02K
2024Q1
127
376.48K
58.41%
+13.40K
2023Q4
110
351.78K
54.63%
-16.53K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
1.41M
10.18%
+490.00
+0.03%
Sep 30, 2025
BVF Partners L.P.
1.39M
9.99%
--
--
Sep 30, 2025
Fairmount Funds Management LLC
2.75M
19.78%
+1.36M
+97.99%
Dec 04, 2025
VR Adviser, LLC
1.39M
9.99%
--
--
Sep 30, 2025
Forbion Capital Partners
1.68M
12.08%
+1.68M
--
Dec 08, 2025
1Globe Capital, L.L.C.
1.43M
10.26%
+528.72K
+58.96%
Oct 07, 2025
Tang Capital Management, LLC
700.00K
5.04%
+20.18K
+2.97%
Oct 02, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
Avantis US Small Cap Equity ETF
Proportion0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Jun 05, 2025
Merger
100→1
Date
Ex-dividend Date
Type
Ratio
Jun 05, 2025
Merger
100→1
